CCL23 and neoplasm: Here, we describe a novel perspective of a CC-chemokine ligand (CCL23) in context with HCC tumor development and its potential in mitigating the ER stress leading to remodeling the HCC tumor microenvironment in favor of enhanced antitumor immunity.